Pathalys Pharma, Inc. logo
Pathalys Pharma, Inc. logo

Pathalys Pharma, Inc.

pathalys.com
pathalys.com • Likely startup • New
Likely startup • New
Actively hiring
Biologics & Biosimilars
Biotechnology
Health Care
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Backers
1
OrbiMed
Momentum
0/100
no fresh signals
Backed byfrom the funds' portfolios and accelerator catalogs
OrbiMed fund
Similar startupsby what they do, their industry and backers
Evlabio11-50 employees
Creating innovative therapies for chronic kidney disease patients. Addressing left ventricular hypertrophy with monoclonal antibody…
Angitia Biopharmaceuticals
Angitia is a clinical-stage biotechnology company focused on discovering and developing breakthrough therapeutics that address the key…
Serca PharmaceuticalsFounded 2018 • 201-500 employees
Our mission is to improve the quality of life of patients with myocardial infarction (MI) and heart failure by providing novel…
RenasantBioVenture round $30M · 15 mo ago • Founded 2022 • 51-200 employees
Correctors and Potentiators for Autosomal Dominant Polycystic Kidney Disease (ADPKD). Transforming the Treatment of ADPKD.
AttralusVenture round $56M · 2 yr ago • Founded 2019
Attralus is focused on advancing new solutions for amyloidosis therapy. The team has deep experience in Amyloid research and therapeutic…
Opna BioFounded 2020 • 51-200 employees
Opna Bio is a clinical-stage biopharmaceutical company focused on the discovery and development of novel oncology therapeutics. The…

Overview

A new path forpatients with Chronic Kidney Disease. At Pathalys Pharma, Inc. we are committed to improving the lives of patients through the development of enhanced therapeutics that improve the management of chronic kidney disease (CKD).